NCT00345813View on ClinicalTrials.gov

Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

soy isoflavones

Given orally

DIETARY_SUPPLEMENT

soy protein isolate

Given orally

OTHER

placebo

Given orally

Trial Locations (1)

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00345813 - Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer | Biotech Hunter | Biotech Hunter